NO20052954L - Diterpenoidforbindelser, sammensetninger derav og deres anvendelse som anti-cancer eller anti-fungale midler - Google Patents
Diterpenoidforbindelser, sammensetninger derav og deres anvendelse som anti-cancer eller anti-fungale midlerInfo
- Publication number
- NO20052954L NO20052954L NO20052954A NO20052954A NO20052954L NO 20052954 L NO20052954 L NO 20052954L NO 20052954 A NO20052954 A NO 20052954A NO 20052954 A NO20052954 A NO 20052954A NO 20052954 L NO20052954 L NO 20052954L
- Authority
- NO
- Norway
- Prior art keywords
- cancer
- compositions
- compounds
- methods
- useful
- Prior art date
Links
- -1 Diterpenoid compounds Chemical class 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 4
- 230000001093 anti-cancer Effects 0.000 title 1
- 229940121375 antifungal agent Drugs 0.000 title 1
- 239000003429 antifungal agent Substances 0.000 title 1
- 239000002246 antineoplastic agent Substances 0.000 title 1
- 238000000034 method Methods 0.000 abstract 4
- 206010028980 Neoplasm Diseases 0.000 abstract 3
- 201000011510 cancer Diseases 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 210000005170 neoplastic cell Anatomy 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 238000002560 therapeutic procedure Methods 0.000 abstract 2
- 206010017533 Fungal infection Diseases 0.000 abstract 1
- 241000233866 Fungi Species 0.000 abstract 1
- 208000031888 Mycoses Diseases 0.000 abstract 1
- 230000006907 apoptotic process Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000001613 neoplastic effect Effects 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/04—Saturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/12—Ketones containing more than one keto group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/121—Ketones acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
- C07C43/14—Unsaturated ethers
- C07C43/162—Unsaturated ethers containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
- C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
- C07C45/292—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with chromium derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/225—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing six-membered aromatic rings and other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
- C07C49/755—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
- C07C2603/26—Phenanthrenes; Hydrogenated phenanthrenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43109602P | 2002-12-05 | 2002-12-05 | |
| PCT/US2003/038659 WO2004052282A2 (en) | 2002-12-05 | 2003-12-04 | Diterpenoid compounds, compositions thereof and their use as anti-cancer or anti-fungal agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20052954D0 NO20052954D0 (no) | 2005-06-16 |
| NO20052954L true NO20052954L (no) | 2005-09-01 |
Family
ID=32507669
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20052954A NO20052954L (no) | 2002-12-05 | 2005-06-16 | Diterpenoidforbindelser, sammensetninger derav og deres anvendelse som anti-cancer eller anti-fungale midler |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7217844B2 (pl) |
| EP (1) | EP1578711A4 (pl) |
| JP (1) | JP2006515292A (pl) |
| KR (1) | KR20050105975A (pl) |
| CN (1) | CN1745054A (pl) |
| AU (1) | AU2003297671A1 (pl) |
| BR (1) | BR0317052A (pl) |
| CA (1) | CA2508002A1 (pl) |
| NO (1) | NO20052954L (pl) |
| PL (1) | PL377303A1 (pl) |
| WO (1) | WO2004052282A2 (pl) |
| ZA (1) | ZA200504466B (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080131968A1 (en) * | 2002-08-28 | 2008-06-05 | Nomir Medical Technologies, Inc. | Near-infrared electromagnetic modification of cellular steady-state membrane potentials |
| US7795311B2 (en) * | 2007-10-15 | 2010-09-14 | Pittsburg State University | Methods and compositions for the management of soil-borne fungal diseases |
| KR20110014974A (ko) * | 2008-03-31 | 2011-02-14 | 썬 파마슈티컬 인더스트리스 리미티드 | 모르피난 유사체의 개선된 제조 방법 |
| CN101880269B (zh) * | 2010-06-30 | 2012-05-23 | 浙江工商大学 | 二萜单体及从大青中分离制备二萜单体的方法 |
| US11826344B2 (en) * | 2015-11-19 | 2023-11-28 | Howard University | Composition, method of manufacture, and use of site-specific delivery of bruceolides for treatment of cancer and other diseases |
| CN108929857B (zh) * | 2017-05-26 | 2021-10-29 | 中国海洋大学 | 一种柳珊瑚来源的海洋真菌及其在制备拓扑异构酶i抑制剂中的应用 |
-
2003
- 2003-12-01 US US10/725,629 patent/US7217844B2/en not_active Expired - Fee Related
- 2003-12-04 EP EP03812814A patent/EP1578711A4/en not_active Withdrawn
- 2003-12-04 CN CNA2003801094415A patent/CN1745054A/zh active Pending
- 2003-12-04 ZA ZA200504466A patent/ZA200504466B/en unknown
- 2003-12-04 WO PCT/US2003/038659 patent/WO2004052282A2/en not_active Ceased
- 2003-12-04 JP JP2004559302A patent/JP2006515292A/ja active Pending
- 2003-12-04 AU AU2003297671A patent/AU2003297671A1/en not_active Abandoned
- 2003-12-04 BR BR0317052-7A patent/BR0317052A/pt not_active IP Right Cessation
- 2003-12-04 CA CA002508002A patent/CA2508002A1/en not_active Abandoned
- 2003-12-04 KR KR1020057010302A patent/KR20050105975A/ko not_active Withdrawn
- 2003-12-04 PL PL377303A patent/PL377303A1/pl not_active Application Discontinuation
-
2005
- 2005-06-16 NO NO20052954A patent/NO20052954L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20050070540A1 (en) | 2005-03-31 |
| NO20052954D0 (no) | 2005-06-16 |
| WO2004052282A2 (en) | 2004-06-24 |
| AU2003297671A1 (en) | 2004-06-30 |
| JP2006515292A (ja) | 2006-05-25 |
| CN1745054A (zh) | 2006-03-08 |
| ZA200504466B (en) | 2006-10-25 |
| US7217844B2 (en) | 2007-05-15 |
| BR0317052A (pt) | 2005-10-25 |
| PL377303A1 (pl) | 2006-01-23 |
| EP1578711A4 (en) | 2006-09-27 |
| CA2508002A1 (en) | 2004-06-24 |
| EP1578711A2 (en) | 2005-09-28 |
| KR20050105975A (ko) | 2005-11-08 |
| WO2004052282A3 (en) | 2004-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE411022T1 (de) | Pyridylpyrrol-derivate als wirksame kinase-hemmer | |
| CY1110013T1 (el) | Συνδυασμοι για θεραπεια πολλαπλου μυελωματος | |
| EA200501849A1 (ru) | Производные пиразолохиназолина: способ получения и применение в качестве ингибиторов киназ | |
| DK1689724T3 (da) | Quinazolinonforbindelser som anticancermidler | |
| WO2004103274A3 (en) | Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases | |
| TW200500355A (en) | Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases | |
| NO20054988L (no) | Preparater og metoder for behandling av cancer | |
| TW200621240A (en) | Cancer treatments | |
| BR0315912A (pt) | Compostos pirimìdicos com atividade antiproliferativa (ii) | |
| WO2007075554A3 (en) | Combination of igfr inhibitor and anti-cancer agent | |
| ECSP055525A (es) | Inhibidores de cinasas de tirosina | |
| AR048502A1 (es) | Sinergia terapeutica de compuestos anti-cancer | |
| BR0315337A (pt) | Composto, formulação farmacêutica, e, método para tratar câncer | |
| BRPI0417158A (pt) | composto, composição farmacêutica, uso de um composto, método para prevenir, tratar ou melhorar uma doença ou condição associada com angiogênese desregulada, e, métodos para tratar ou melhorar cáncer, para reduzir o potencial metastático de um tumor, e para tratar ou melhorar tumores, e uma condição ou doença | |
| BRPI0415953B8 (pt) | formulação de dosagem de liberação controlada e conjunto de formas de dosagem de liberação controlada | |
| DK1390371T3 (da) | Oxazolo- og furopyrimidiner samt deres anvendelse i lægemidler mod tumorer | |
| ATE238981T1 (de) | Antitumorwirkstoffe | |
| MXPA04007584A (es) | Compuestos de poliamina y composiciones para su uso en conjunto con una terapia contra el cancer. | |
| BRPI0414736A (pt) | 5-aril-pirimidinas como agentes anticáncer | |
| DE59911734D1 (de) | Kombination von selen-haltigen verbindungen mit gemcitabin oder mitomycin c | |
| BR0017120A (pt) | Composição farmacêutica | |
| NO20052954L (no) | Diterpenoidforbindelser, sammensetninger derav og deres anvendelse som anti-cancer eller anti-fungale midler | |
| WO2006089406A8 (en) | Diterpenoid compounds, compositions thereof and their use as anti-cancer or anti-fungal agents | |
| EP1374873B8 (en) | The use of n-acetyl-d-glucosamine in the manufacture of pharmaceutical useful for supressing side-effect of radiotherapy and chemotherapy | |
| DE60309926D1 (de) | Steroid-verbindungen mit anti-tumoraler wirkung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |